100
Participants
Start Date
June 30, 2025
Primary Completion Date
April 1, 2026
Study Completion Date
April 1, 2028
HistoSonics Edison® System
Histotripsy is a novel, totally non-invasive, non-ionizing, and non-thermal ablation technique that mechanically disrupts tumors through precisely controlled acoustic cavitation. Histotripsy is administered via HistoSonics Edison® System.
Chemotherapy
Chemotherapy (standard of care with first line therapy of base of 5-FU with either oxaliplatin or irinotecan).
RECRUITING
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Collaborators (1)
HistoSonics, Inc.
INDUSTRY
Case Comprehensive Cancer Center
OTHER